Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Regulating medical devices
- Latest information for patients
- About MHRA
- All MHRA services and information
Featured
Patients urged to check packs of blood pressure medicine lercanidipine after labelling error
Press release
Patients who take the common blood pressure medicine Lercanidipine HCI 20mg tablets (lercanidipine hydrochloride) from the manufacturer Recordati Pharmaceuticals Limited, should, as a precautionary measure, urgently check if they have the batch number MD4L07 with an expiry date of 01/2028 on any packs they have at home. The batch number is printed on the foil of the blister strips.
Clinical Trials regulations signed into law
Press release
12-month roll-out begins today for the biggest regulatory shake up of clinical trials in 20 years
First-ever MHRA analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients
Press release
New analysis of the current clinical trial landscape in the UK shows clear opportunities to shape the future of medical research and patient care.
As with all products, the MHRA will keep its safety under close review.
Lawrence Tallon begins role as new MHRA CEO
Press release
Lawrence Tallon today (1 April 2025) begins his role as Chief Executive Officer of the Medicines and Healthcare products Regulatory Agency (MHRA).
The World Health Organization (WHO) has confirmed the successful redesignation of the Medicines and Healthcare products Regulatory Agency (MHRA)’s Science and Research group as one of its Collaborating Centres for the Standardisation and Evaluation of Biologicals for the next four years.
Latest from the Medicines and Healthcare products Regulatory Agency
Subscriptions
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Transparency and freedom of information releases
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA10 South Colonnade
London
E14 4PU
United Kingdom
Telephone (including out of hours):
020 3080 7651
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom